Vesomni Tablets Defect Notification - Incorrect Barcode

The MHRA issued a Class 4 Medicines Defect Notification regarding Quadrant Pharmaceuticals Limited's Vesomni 6 mg/0.4 mg modified release tablets. The parallel imported packs have an incorrect barcode/GTIN on the carton, but the product quality is unaffected. No recall is issued, and patients do not need to take action.

MHRA and HSA Collaborate on Healthcare Regulatory Innovation

The MHRA and Singapore's HSA have refreshed a Memorandum of Understanding to collaborate on healthcare regulatory innovation, focusing on emerging technologies like AI and advanced therapies. This partnership aims to accelerate patient access to innovative treatments while maintaining safety and trust through initiatives like work-sharing and a new Regulatory Innovation Corridor pilot.

DOJ FOIA Training Dates Announced

The Department of Justice's Office of Information Policy (OIP) has announced new dates for its virtual Freedom of Information Act (FOIA) training sessions for April through July 2026. These sessions are designed for federal government employees and contractors involved in FOIA responsibilities.

DOJ Secures Denaturalization of Gun Trafficker and Health Care Fraudster

The Department of Justice announced the denaturalization of Vladimir Volgaev, a convicted gun trafficker and health care fraudster, for concealing his crimes during the naturalization process. The department also filed a complaint against a marriage scammer and secured the denaturalization of another individual for Medicare fraud.

USPTO Patent Application for Medical Testing and Treatment Protocols

The USPTO has published a patent application (US20260088141A1) for a system and method to determine medical testing and treatment protocols. The application, assigned to Intervention Insights, Inc., outlines a process for matching patient profiles to cohorts to identify appropriate tests and treatments.

USPTO Patent Application for Continuous Patient Authentication

The USPTO has published a patent application (US20260087119A1) for systems and methods related to continuous patient authentication. The application describes techniques for passive authentication using sensor data to allow access to medical device software without user prompts.

USPTO Patent Application: Dementia with Lewy Bodies Identification Method

The USPTO has published a patent application detailing a method for identifying Dementia with Lewy Bodies (DLB) using DNA methylation patterns. The application, filed by inventors from Spain, describes a diagnostic technique involving mitochondrial DNA analysis and provides for classification models, oligonucleotides, and kits.

USPTO Patent Application: Radiation Dose Optimization for Particle Emitter

The USPTO has published a new patent application detailing a method for concurrent optimization of radiation doses for particle emitter devices across multiple treatment phases. The application, filed by Roni Hytonen, Perttu Niemelä, and Lauri Halko, aims to improve treatment efficacy by dynamically adjusting radiation doses based on phase-specific objectives.

USPTO Patent Application: Medicament Delivery Device Dosage Adjustment

The USPTO has published a patent application detailing a medicament delivery device that adjusts dosages based on a user's menstrual cycle phase. This technology aims to improve blood glucose control for users by reducing the risk of hyperglycemia and hypoglycemia.

USPTO Patent Application for Insulin Delivery Methods

The USPTO has published a patent application (US20260083910A1) detailing new methods, systems, and devices for insulin delivery. The application, filed on December 1, 2025, by inventors Bryan Mazlish and Lane Desborough, focuses on responsive basal insulin delivery rates and variable duration instructions for insulin delivery devices.